IL6 and cancer: Sixthly, only one variant in IL-6 gene was selected, and investigation on other candidate genes or polymorphisms involved in IL-6 regulation was highly encouraged, leaving a challengeable task to test whether this variant integrated with other risk determinants will enhance cancer risk prediction.